Upload
others
View
6
Download
0
Embed Size (px)
Citation preview
USP Botanical standards – a comprehensive approach to quality
Complementary Medicines Australia, October 09, 2019
Nandu Sarma, Ph.D.,Director, Dietary Supplements and Herbal Medicines
2© 2017 USP
Outline USP’s public standard-setting process
and regulatory recognition
Botanical drugs and dietary supplements – quality requirements
Unique challenges and complexities of botanical ingredients
Emerging topics in botanical quality controls
2© 2018 USP
Who we are
4© 2017 USP
4
We exist to …▸ Protect patient safety▸ Advance public health▸ Foster competition for more affordable
quality medicines
We are an ‘organization of organizations’▸ Governed by the USP Convention▸ 450 academic institutions; healthcare
practitioner, patient and industry groups; and governmental orgs
We are science-based▸ Not-for-profit and independent
We are powered by …▸ 900+ experts from science and health who set USP
quality standards▸ 100 FDA staff participate in the process
About USP
5© 2017 USP
USP standards are set by Expert Committees
Expert Committees
Board of Trustees &
Board Committees USP Staff
AdvisoryBodies
Expert Panels
Workinggroups
Stakeholderforums
6© 2017 USP
The Experts Behind Our Standards
2015–2020 Expert Committees
7© 2017 USP
USP – Public Standards
Hello, user
USP standards used in over 140 countries
8© 2017 USP
Monographs
General Test Chapters
General Notices (GN)
USP–NF
USP Monographs, General Chapters and General Notices
General Notices provides the basic assumptions and definitions for applying USP−NF compendialstandards, which are applied to official articles recognized in monographs and any applicable general chapters
General Chapters contain requirements applicable to monographs to which they apply
Monograph requirements are specific to the monograph in which they appear. Monograph requirements supersede General Notice and General Chapter requirements in case of a conflict
9© 2017 USP
New Dietary Supplements Compendium Online
Online.uspdsc.com/
500+ dietary supplement monographs
170 General Chapters
> 175 excipient (NF) monographs
> 200 Food Chemicals Codex (FCC) monographs
68 DSC admission evaluations
>150 added pages of color plates and illustrations
12© 2017 USP
USP Reference Standards- A benchmark for quality
13© 2017 USP
Developing Standards
14© 2017 USP
Dietary Supplement Admission Evaluation Process
Evaluation of Information by EC
https://www.usp.org/sites/default/files/usp/document/get-involved/submission-guidelines/guideline-for-the-admission-of-dietary-supplement-ingredients.pdf
15© 2017 USP
USP publications
16© 2017 USP
17© 2017 USP
Factors impacting pharmacopeial standards
Regulations – DSHEA and DSHEA-like –Compliance with Pharmacopeia: Voluntary or mandatory
Global supply chain
New technologies
Adulteration
Contaminants, such as pesticide residues
Partners in industry
R&D companies and generic
manufacturers
Partners in science With academics,
practitioners
Partners in governmentWith regulatory and health authorities
Partnerships at the heart of quality
18© 2018 USP
19© 2017 USP
USP Standards in the Law
Federal Food, Drug, and Cosmetic ActSections 201 (g) and (j), 501(b), 502(g)USP and NF standards FDA enforceable for all drugs.Conformance is generally not optional.
Dietary Supplement Health & Education Act (DSHEA)Section 403(s)(2)(D) of the FD&C ActA dietary supplement represented as conforming to specifications from an official compendium (USP-NF) shall be deemed misbranded if it fails to do so. FDA enforceable.
Conformance is optional.
20© 2017 USP
Preamble to the 2003 CGMP Proposal (68 FR 12157 at 12208 and 12209):
Validated methods and the role of the official compendia: “We explicitly stated that you may use validated methods that can be found in official references, such as AOAC International, USP, and others.”
20
Use of Compendial Standards
Use of compendial reference standards: “…we noted that compendial standards may be appropriate reference materials for use in conducting tests or examinations.”
21© 2017 USP
Failed to ensure that the tests are appropriate, scientifically valid methods, as required by 21 CFR 111.75(h)(1). Specifically:
•Black cohosh and ashwagandha: Organoleptic analysis of appearance, color, odor, and taste. No RS and no written acceptance criteria to define any of these characteristics.
•Kelp and ashwagandha: Identification using FTIR. The RS used to compare the spectra were a previous lot of kelp and ashwagandha. There was no written acceptance criteria established for the passing identification test.
Non-compendia reference standard materials should be of the highest purity by reasonable effort and should be thoroughly characterized to ensure their identity, purity, quality, and strength.
Common GMP violation: Failure to meet requirement for scientifically valid methods
http://www.fda.gov/iceci/enforcementactions/warningletters/2014/ucm417209.htm
22© 2017 USP
Recognition of USP standards in Australia
https://www.tga.gov.au/publication/compositional-guidelines
23© 2017 USP
Outline USP’s public standard-setting process
Botanical drugs and dietary supplements – quality requirements
Unique challenges and complexities of botanical ingredients
Emerging topics in botanical quality controls
23© 2018 USP
24© 2017 USP
GMPs require specifications for quality
“Quality means that the dietary supplement consistently meets the established specifications for identity, purity, strength, and composition, and limits on contaminants,…”
− §111.75(a)(1)(i) Your must conduct at least one appropriate test or examination to verify the identity ...
− §111.75 (h)(1) You must ensure that the tests and …the specifications are .. appropriate, scientifically valid methods.
25© 2017 USP
Specifications
Specification:– a list of tests, – analytical procedures, and – appropriate acceptance criteria
The set of criteria to which a .. product should conform to be considered acceptable for its intended use.
Critical quality standards that are proposed and justified by the manufacturer.
26© 2017 USP
Intact plant material-------------------------------------------------------------------------------------------------------------------Single chemical entity
Whole
Turmeric Root
Powdered plant material
Native/Full spectrumExtracts
Enriched Extracts
IsolatedClass of compounds
PurifiedSingle Chemical
TurmericPowder
TurmericDry Extract
Turmeric CurcuminoidExtract
Curcuminoids Curcumin
Degree of Purification
Degree of Complexity
Complexity of Natural Products
http://www.usp.org/sites/default/files/usp/document/get-involved/submission-guidelines/guideline-for-assigning-titles-to-usp-dietary-supplement-monograph.pdf
Degree of Purification
27© 2017 USP
Botanicals in USP
Drugs Excipients• Acacia• Mint• Tragacanth• Cardamom• Vanilla• Cinnamon
Dietary Supplements
• Ginseng, American / Asian / Tienchi
• Andrographis• Ashwagandha
• Bacopa• Banaba• Black cohosh• Black pepper• Boswellia
• Centella asiatica• Chamomile• Chinese Salvia• Green tea • ……….
• Witch Hazel• Psyllium• Digitalis• Rauwolfia• Cascara Sagrada• Senna
• Aloe• Plantago• Belladonna• Opium• Myrrh
28© 2017 USP
USP Powdered Decaffeinated Green Tea Extract –Dietary Supplement monograph
29© 2017 USP
Monograph title (Nomenclature guidelines)
Definition: botanical characteristics of the plant (genus, species, variety, chemotype), parts of the plants
Identity: macroscopical and microscopical characterization, phytochemical characteristics, profile of the constituents
Strength and Composition: constituents with known activity or markers, toxic constituents (identity, assay, limit tests)
Contaminants (microbial levels, aflatoxins, heavy metals, residues of pre-/post-harvest chemical treatments such as pesticides, fumigants)
Labeling
USP Specifications for botanical ingredients
30© 2017 USP
AccuracyPrecisionSpecificityLoD / LoQLinearityRobustness
The Science of the Standards
Method Validation criteria
31© 2017 USP
Monograph Specifications
Consistency with
21CFR111–Identity–Purity–Strength–Composition–Absence of Contaminants
© 2017 USP31
32© 2017 USP
USP Powdered Ginkgo Extract
• Identification: HPTLC and HPLC tests for the ratio and relative abundance of the flavonol glycosides and terpene lactones.
• Composition: Contents of flavonol glycosides (22% - 27%); terpene lactones(5.4% - 12.0%); bilobalide (2.6% - 5.8%).
• Limits for contaminants: Pesticide residues; elemental impurities; microbial load; Limit of residual solvents.
• Specific tests: Limits for rutin and quercetin; Limits for Ginkgolic acid.
33© 2017 USP33
Complementary tests in Public Standards
34© 2017 USP
USP General Chapters
Specific for Dietary Supplements:Microbial Enumeration Tests, Nutritional and Dietary Supplements
Microbiological Procedures for Absence of Specified Microorganisms, Nutritional and Dietary Supplements
Microbiological Attributes of Non-sterile Nutritional and Dietary Supplements
Disintegration and Dissolution of Dietary Supplements
Weight Variation of Dietary Supplements
Elemental Contaminants in Dietary Supplements
Detection of Irradiated Dietary supplements
Screening Methods for Undeclared Drugs and Drug analogs
Manufacturing Practices for Dietary Supplements
<2021>
<2022>
<2232>
<2040>
<2091>
<2750>
<2250>
<2251>
<2023>
35© 2017 USP
USP General Chapters
Non-specific for Dietary Supplements:
<467>
<561>
<563>
<621>
HPTLC
Residual Solvents
Articles of Botanical Origin
Identification of Articles of Botanical Origin
Chromatography
<203>
36© 2017 USP
Outline USP’s public standard-setting process
Botanical drugs and dietary supplements – quality requirements
Unique challenges and complexities of botanical ingredients
Emerging topics in botanical quality controls
36© 2018 USP
37© 2017 USP
Specifications for Contaminants
• Limits for pesticide residues ARTICLES OF BOTANICAL ORIGIN <561>: Meets the requirements
• MICROBIAL ENUMERATION TESTS ⟨2021⟩:
• total bacterial count NMT 105 cfu/g,
• the total combined molds and yeasts count NMT 103 cfu/g
• the bile-tolerant Gram-negative bacterial count NMT 103 cfu/g
• ABSENCE OF SPECIFIED MICROORGANISMS ⟨2022⟩: absence of Salmonella species and Escherichia coli.
© 201 USP9
37
38© 2017 USP
<561> Articles of Botanical Origin• For products marketed in U.S. as foods, including dietary supplements,
<561> requires compliance to EPA (40 CFR 180) and FDA action levels (21 CFR 109; 21 CFR 509)
• Specifications in <561> are applicable to botanical drugs (e.g., psyllium husk), but not dietary supplements in U.S. (even for the same ingredient)
© 201 USP9
38
39© 2017 USP
• The MRLs in <561> are based on WHO-FAO ADIs, but are limited to the 90th percentile of the pesticide levels found on the herbs of commerce, i.e., readily accomplished under GACP
• USP compendial approach sets limits based on risk, and does not set not crop-specific limits
• USP <561> MRLs are harmonized with those of Ph. Eur.
• EPA MRLs are based on a submission from a pesticide manufacturer for intended uses of the pest control product on specific crops
USP Limits for Pesticide Contaminants
© 201 USP9
39
40© 2017 USP
Pesticide Contamination in Botanical IngredientsThe Challenge:
EPA established tolerances are plant/pesticide specific
Unintentional pesticide contamination (point-source or non-point-source) due to environmental conditions is ubiquitous
Zero-tolerance limit exists for any residue without specified level
Zero tolerance is not useful for making safety based decisions –new technologies go to ppb levels
40© 2018 USP
41© 2017 USP
Outline USP’s public standard-setting process
Botanical drugs and dietary supplements – quality requirements
Unique challenges and complexities of botanical ingredients
Emerging topics in botanical quality controls
41© 2018 USP
42© 2017 USP
42© 2018 USP
Emerging Technologies
DNA-based ID
NMR
Chemometrics
Digital standards and Databases
Non-targeted methods
Metabolomics
43© 2017 USP
DNA-based methods are useful for botanical ingredient ID– High degree of specificity and sensitivity
– Can distinguish closely related or morphologically similar species
Considerations for DNA-based identification
DNA-based methods are not suitable as the sole basis for ID
– May not be suitable for botanical extracts, unless validated
– False negative results from processed ingredients or due to interferences from the matrix
– False positive results from foreign organic matter naturally occurring in the plant material at low but allowable levels (NMT 2%)
– No guarantee of appropriate Good Agricultural Practices
– May be fooled by deliberate addition of small amounts of raw material
Suitable as an orthogonal test which measures a unique attribute
44© 2017 USP
DNA Methods for Botanical Identification
45© 2017 USP
min0 10 20 30 40 50 60 70
mAU
0
20
40
60
80
100
DAD1 A, Sig=203,16 Ref=360,100 (YITAO\COMPARE\RS1.D)
Rg1Re
Rb1
RcRb2
Rd
min0 10 20 30 40 50 60 70
mAU
0
25
50
75
100
125
150
175
DAD1 A, Sig=203,16 Ref=360,100 (G:\2D(1)~1.D)
Rd
Rb2
Rb2
Re
Rg1
N-R1
min0 10 20 30 40 50 60 70
mAU
0
50
100
150
200
DAD1 A, Sig=203,16 Ref=360,100 (HUPING~2\XY090316.D)
Rg1
ReRb1
RcRb2
Rd
Asian Ginseng
American Ginseng
Notoginseng Rb1
Unique species identifiers
Rf
F11
46© 2017 USP
HPTLC-based ID
← Rg1
← R1 ← Re ← Rd
← Rb1
← Rg1
← ReRf →
←Rd
← Rc← Rb2
↖ Ro/Rb1
47© 2017 USP
Polymerase Chain Reaction (PCR) Method
Step 1: Extract DNAStep 2: Amplify with species specific primers Step 3: Run gel electrophoresis and look for specific bands
48© 2017 USP
Species Specific Primer Design Strategy
Sequence variations
100-200 base pairs, optimal
18-30 base pair, GC content between 40-60%
49© 2017 USP
Learnings
Pilot studies on species-specific test methods using authenticated and commercial samples demonstrate ability to discriminate; further method development, optimization and validation is still needed.
The studies demonstrate value of orthogonal methods for identification
Orthogonal tests increase confidence on identity based on unique attributes
OOS investigation protocols are needed to address false negative tests due to matrix (such as red ginseng or extracts) which impact DNA extraction or false positives due to contamination
Sequence verification of amplicons using Sanger and NGS as appropriate
Optimization of nucleic acid extraction
51© 2017 USP
The criteria for positive and negative control species In silico design of the primers with specificity as an attribute
• Available genome sequence databases, their limitations Validation criteria for species-specific identification
• Controls to identify interspecies variability and avoid unintended target amplification • Optimization of amplification conditions • Criteria for repeatability and reproducibility (multi-lab studies) • criteria and tools for sequence matching, where used
Verification of the methods • System suitability controls including QC for DNA extraction and quantification, • Matrix related challenges such as extracts, leaf versus bark, etc• Use of reference standards for comparison – reference raw material and whole genomic DNA
Acceptance criteria • Controls for false positive non-specific amplification and false negative no amplification outcomes
Brief description of available methods and technologies for detection Use of orthogonal methods Out of Spec investigations
Proposed revision for <563>
52© 2017 USP
Final Remarks
53© 2017 USP
The Value of Public Standards
53© 2018 USP
Provides scientific basis for decision making
Ensures a consistent approach to quality
Useful for monitoring of counterfeit and substandard products and quality
Appropriate titles Useful definitions Validated methods Established limits
54© 2017 USP
USP Botanical Priorities
Central to USP’s achievements are the contributions of countless professionals, who volunteer their time and knowledge in USP’s Council of Experts and Expert Committees and Panels.
Our Call for Candidates is now open.
Join other motivated colleagues to help us set the standards that make it possible for 2 billion people around the world to have access to quality medicines, foods and dietary supplements.
Contact us at [email protected]
56© 2017 USP
Global Supply Chain - The Role for Public Standards
Common standard for both buyers and sellers (basis of
contractual agreements)
Methods must be reliable enough to ensure that buyers and sellers arrive at the same
value
58© 2017 USP
Thank You